Skip to content
healthcare.dev

Tasigna

NDC 0078-0526, nilotinib, capsule, from Novartis Pharmaceuticals Corporation.

Product NDC
0078-0526
Status
Listed
Labeler
Novartis Pharmaceuticals Corporation
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA022068
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0526 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NILOTINIB HYDROCHLORIDE MONOHYDRATE200 mg/1

Pharmacologic classes

Bcr-Abl Tyrosine Kinase Inhibitors [MoA]; Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2C8 Inducers [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Kinase Inhibitor [EPC]; P-Glycoprotein Inhibitors [MoA]; UGT1A1 Inhibitors [MoA]

Package NDCNDC-11Package
0078-0526-510007805265128 CAPSULE in 1 BLISTER PACK (0078-0526-51)
0078-0526-87000780526874 BLISTER PACK in 1 CARTON (0078-0526-87) / 28 CAPSULE in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6093952a-5248-45cb-ad17-33716a411146

Use it

Look up 0078-0526 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0526 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0078-0526. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.